| Beyond the Abstract - Present and future therapeutic options for locally ... - UroToday |
|
|
UroToday BERKELEY, CA (UroToday.com) - Until recently, immunotherapy was considered the only therapeutic option for patients with advanced and metastatic renal cell carcinoma (RCC). Considering the fact that RCC is resistant to radiotherapy and to the standard |